Picture of Orthopediatrics logo

KIDS — Orthopediatrics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

OrthoPediatrics Corp expected to post a loss of 40 cents a share - Earnings Preview

* OrthoPediatrics Corp  KIDS.OQ   KIDS.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 6 for
the period ending March 31 2024
    * The Warsaw Indiana Indiana-based  company is expected to
report
a 32.2% increase in revenue to $41.775 million from $31.59
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for OrthoPediatrics Corp is
for a
loss of 40 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
OrthoPediatrics
Corp is $38.50​, above​ its last closing price of $32.83. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.28       -0.28      -0.29     Missed  -3.4
 Jan. 1 2023   -0.23       -0.23      -0.20     Beat    10.3
 Jun. 30 2023  -0.20       -0.22      -0.13     Beat    39.9​
 Mar. 31 2023  -0.37       -0.36      -0.30     Beat    17.8
 ​​Dec.        -0.23       -0.25      -0.35     Missed  -38.4
 31 2022                                                
 Sep. 30 2022  -0.20       -0.20      -0.07     Beat    65.7​
 Jun. 30 2022  -0.22       -0.21      -0.02     Beat    90.7
 Mar. 31 2022  -0.38       -0.37      -0.47     Missed  -26.7
 This summary was machine generated May 4 at 02:59 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Orthopediatrics

See all news